Navigation Links
Novel brain tumor vaccine acts like bloodhound to locate cancer cells
Date:1/5/2012

WINSTON-SALEM, N.C. Jan. 5, 2012 A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.

The vaccine will be tested in patients with newly diagnosed glioblastoma multiforme (GBM), the most aggressive and highest grade malignant glioma. Wake Forest Baptist will treat a minimum of 25 patients in this randomized, placebo-controlled phase II clinical trial of ICT-107. A total of 20 sites across the country are participating in the trial to test the safety and efficacy of this novel cancer vaccine.

All patients enrolled in the study will receive the current standard treatment for GBM, which includes surgery followed by radiation and chemotherapy. Two thirds of the participants will then also get the experimental vaccine treatment, which will be administered in the post radiation phase of treatment, while the others will get a "dummy," or placebo vaccine in addition to standard therapy.

"This vaccine is for newly-diagnosed patients," said Glenn Lesser, M.D., a professor of internal medicine, hematology-oncology, at Wake Forest Baptist and principal investigator for the study. "Scientifically, it's a very well designed study and we are excited to participate in this clinical trial. We've been asked to participate based on our reputation as an outstanding brain tumor center and the expertise our center has with bringing novel therapies and novel therapeutics to patients."

The approach with this particular vaccine is unique, Lesser added, because it is targeting the antigens or proteins that are present on glioma stem cells, whereas other treatment approaches mostly target differentiated tumor cells.

"The antigens used in this vaccine target the tumor stem cells the handful of cells that keep the tumor alive and dividing. Most of the cells we kill with standard treatment are likely not the ones driving the
'/>"/>

Contact: Bonnie Davis
bdavis@wakehealth.edu
336-716-4977
Wake Forest Baptist Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Novel Hepatitis C Vaccine Shows Some Early Promise
2. BUSM researchers identify novel compound to halt virus replication
3. Novel technique could help boost IVF success and reduce multiple pregnancies
4. Novel export-inhibitor shows promise for treating CLL
5. Novel experimental agent is highly active in CLL patients, interim study shows
6. Researchers identify a novel therapeutic approach for liver cancer
7. Novel drug wipes out deadliest malaria parasite through starvation
8. Novel approach to treating breast cancer shows great promise
9. Wayne State receives $1.9 million from NIH to create novel cystic fibrosis treatments
10. Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial
11. Wayne State University to study novel treatment for antibiotic-resistant bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... (PRWEB) November 26, 2014 Loffler Companies ... The Week in Imaging, an online information and news ... This is the sixth consecutive year Loffler has earned ... years. , The Elite Dealer Awards honor the best ... This year’s Elite Dealer honorees were chosen for their ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Rouge, Louisiana (PRWEB) November 26, 2014 ... neck pain relief and specialists in minimally invasive ... K. Samer Shamieh into the rapidly growing provider ... specialists. The addition coincides with the network’s ... reliable medical treatment for Louisiana residents who are ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2
... (BMC) New England Centenarian Study report that for ... age-related diseases (i.e. stroke, cardiovascular disease, diabetes) may ... the avoidance of disability may be a key ... in the February 11th issue of Archives of ...
... of the ovaries has been widely adopted as ... or BRCA2 mutations. A new multicenter study led ... is the first prospective examination of the impact ... were analyzed separately from BRCA1 mutation carriers. All ...
... 11 Team Health Inc.,s parent,company, Team Finance ... the fiscal year and the fourth quarter ended ... the decision to exit the anesthesia,management services business ... existing relationships within this operation and the final,phase ...
... today announced it has extended the enrollment deadline to,March ... medical plan. The new,plans will become effective on May ... can be difficult, and we,have heard retirees, requests for ... Secretary of Administration Naomi Wyatt said.,"Therefore, we are providing ...
... developed at MIT can deliver controlled drug doses to ... as a micro pharmacy. , The film could eventually ... and other diseases. It is among the first drug-delivery ... small electric field. , You can mete out what ...
... million, Five-year Grant, from New York State Department of,Health, ... Lead,Poisoned, NEW YORK, Feb. 11 The Lead ... Montefiore,(CHAM) has been named one of three State Regional ... healthcare delivery for children and,pregnant women with elevated blood ...
Cached Medicine News:Health News:Researchers at BMC find disability does not necessarily follow disease in living to old age 2Health News:Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations 2Health News:Team Finance LLC Announces Fiscal 2007 Results 2Health News:Team Finance LLC Announces Fiscal 2007 Results 3Health News:Team Finance LLC Announces Fiscal 2007 Results 4Health News:Team Finance LLC Announces Fiscal 2007 Results 5Health News:Team Finance LLC Announces Fiscal 2007 Results 6Health News:Team Finance LLC Announces Fiscal 2007 Results 7Health News:Team Finance LLC Announces Fiscal 2007 Results 8Health News:Team Finance LLC Announces Fiscal 2007 Results 9Health News:Team Finance LLC Announces Fiscal 2007 Results 10Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:MIT develops thin-film 'micro pharmacy' 2Health News:Montefiore Lead Poisoning Prevention ProgramNamed One of Three State Regional Resource Centers 2
(Date:11/26/2014)... EMERYVILLE, Calif. , Nov. 25, 2014 ... nanotechnology company focused on the development of ... more accurate testing in hospital and pre-hospital ... Standards Organization (ISO) 13485:2003 certification.  The certification ... (BSI), one of the world,s leading certification ...
(Date:11/26/2014)... , Nov. 25, 2014  Breckenridge Pharmaceutical, ... a multi-product ANDA agreement with Pii (Pharmaceutics International, ... under which Breckenridge and Pii expect to develop ... of the agreement, Pii will develop, manufacture and ... distribute the products under its own label.  The ...
(Date:11/26/2014)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 3, ... Helen Torley , President and Chief Executive Officer, will ... webcast through the "Investors" section of Halozyme,s corporate website at ... for 90 days following the event. To access the live ...
Breaking Medicine Technology:Nanomix Receives ISO 13485:2003 Certification 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... Baxano, Inc. ( www.baxano.com ) today announced the closing ... funding, led by new investor CMEA Capital.   Funds were also ... and existing investors Prospect Venture Partners, Three Arch Partners, and Kearny ... , ...
... China , June 22 /PRNewswire-Asia-FirstCall/ -- ... "Company"), a,developer, manufacturer and distributor of botanical products,bio-pharmaceuticals ... Company plans to launch its new all-natural anti-depressant ... Tablets"), a,single plant based medicine, in July ...
Cached Medicine Technology:Baxano, Inc. Announces Close of $30 Million Series C Funding 2Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 2Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 3Renhuang to Launch New All-Natural Anti-depressant and Nerve Regulation Product - Compound Schisandra Tablets 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: